{"id":1297,"date":"2022-11-16T09:00:00","date_gmt":"2022-11-16T09:00:00","guid":{"rendered":"https:\/\/lee-pharm.com\/media-interview-by-southern-finance-omnimedia-group-nansha-plan-driving-rd-and-creating-new-opportunities-for-pharmaceutical-industry\/"},"modified":"2026-09-24T09:24:37","modified_gmt":"2026-09-24T09:24:37","slug":"media-interview-by-southern-finance-omnimedia-group-nansha-plan-driving-rd-and-creating-new-opportunities-for-pharmaceutical-industry","status":"publish","type":"post","link":"https:\/\/lee-pharm.com\/en\/media-interview-by-southern-finance-omnimedia-group-nansha-plan-driving-rd-and-creating-new-opportunities-for-pharmaceutical-industry\/","title":{"rendered":"Media Interview by Southern Finance Omnimedia Group \u2014\u2014 Nansha Plan: Driving R&D and Creating new opportunities for pharmaceutical industry"},"content":{"rendered":"

State Council announced the \u201cGeneral Plan of Nansha, Guangzhou for Deepening Globally Oriented Comprehensive Co-operation amongst Guangdong, Hong Kong and Macau\u201d (Nansha Plan) in June 2022 and implemented taxation rate adjustment in Nansha recently. Dr. LI Xiaoyi, the Founder and Director of Lee\u2019s Pharmaceutical Holdings Limited (\u201cLee\u2019s Pharm\u201d or \u201cthe Group\u201d, HKEx:00950) was interviewed by Southern Finance Omnimedia Group about the benefits of Nansha Plan that illustrate the development in pharmaceutical industry and advancement of technology.<\/p>\n

\u0e14\u0e32\u0e27\u0e19\u0e4c\u0e42\u0e2b\u0e25\u0e14\u0e02\u0e48\u0e32\u0e27\u0e09\u0e1a\u0e31\u0e1a\u0e40\u0e15\u0e47\u0e21 (PDF)<\/a><\/p>\n

\u0e17\u0e35\u0e48\u0e21\u0e32: Lee’s Pharmaceutical Holdings \u2013 News & Media<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"

State Council announced the \u201cGeneral Plan of Nansha, Guangzhou for Deepening Globally Oriented Comprehensive Co-operation amongst Guangdong, Hong Kong and Macau\u201d (Nansha Plan) in June 2022 and implemented taxation rate adjustment in Nansha recently. Dr. LI Xiaoyi, the Founder and Director of Lee\u2019s Pharmaceutical Holdings Limited (\u201cLee\u2019s Pharm\u201d or \u201cthe Group\u201d, HKEx:00950) was interviewed by […]<\/p>\n","protected":false},"author":1,"featured_media":1298,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32,29],"tags":[],"class_list":["post-1297","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lees-pharm-group-news","category-news"],"_links":{"self":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/comments?post=1297"}],"version-history":[{"count":1,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1297\/revisions"}],"predecessor-version":[{"id":1299,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1297\/revisions\/1299"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/media\/1298"}],"wp:attachment":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/media?parent=1297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/categories?post=1297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/tags?post=1297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}